BackWeLeader Biomedical , Ltd. Overview

WeLeader Biomedical , Ltd. Receivables

Track WeLeader Biomedical , Ltd.'s receivables ($360M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$359.97M
↑ 21.99% YoYΔ $64.89M vs prior year quarter

Peer trimmed avg / median

Loading

WeLeader Biomedical , Ltd. Receivables History

Loading

WeLeader Biomedical , Ltd. vs. peers: Receivables Comparison

Loading

WeLeader Biomedical , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

WeLeader Biomedical , Ltd. (7713.TWO) FAQ

WeLeader Biomedical , Ltd. (7713.TWO) currently reports a receivables of $360M as of June 2026. That compares with $300M in the prior-year period — up 22.0% year over year. Use the charts on this page to explore WeLeader Biomedical , Ltd.'s receivables history and peer comparisons.

WeLeader Biomedical , Ltd.'s receivables increased from $300M to $360M — a 22.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

WeLeader Biomedical , Ltd. reported $360M in receivables as of June 2026. That compares with $300M in the prior-year period — up 22.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $360M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for WeLeader Biomedical , Ltd., and consider following 7713.TWO for alerts when major investors trade the stock.